Supporting Type 1 and Type 2 Diabetes Care in the Hemodialysis Unit: A Quality-improvement Initiative Throughout the COVID-19 Pandemic

Can J Diabetes. 2024 Feb;48(1):3-9.e7. doi: 10.1016/j.jcjd.2023.07.010. Epub 2023 Aug 6.

Abstract

Objective: People living with diabetes mellitus (DM) and chronic kidney disease can have difficulty attending multiple appointments to receive DM care. We developed and studied the utility of a DM outreach program to offer in the hemodialysis (HD) unit.

Methods: We conducted a quality improvement project in a satellite HD unit in London, Ontario, Canada, between August 1, 2019, and July 31, 2022. We assessed for baseline gaps in DM care among those with DM, performed root-cause analysis with key stakeholders to identify critical drivers of gaps, and conceptualized a certified diabetes educator-led outreach program to offer in the HD unit. We aimed to improve DM self-monitoring, hypo- and hyperglycemia, and DM-related screening. We used run and control charts to track outcome measures over time and modified our outreach program iteratively.

Results: Fifty-eight persons with DM receiving HD participated in our program. Support spanned multiple waves of the COVID-19 pandemic. With 4 tests of change, we observed improvement in DM self-monitoring with a modest decline in self-reported hyperglycemia. There were no adverse consequences, and satisfaction with our program was high.

Conclusions: Although we did not meet all measures of success during the pandemic, outreach DM support in the HD unit appeared to improve self-monitoring and self-reported hyperglycemia. Similar programs could be modified and implemented in other centres.

Keywords: amélioration de la qualité; chronic kidney failure; diabetes; diabète; hemodialysis; hémodialyse; insuffisance rénale chronique; quality improvement.

MeSH terms

  • COVID-19* / epidemiology
  • Diabetes Mellitus, Type 2* / etiology
  • Hemodialysis Units, Hospital
  • Humans
  • Hyperglycemia* / epidemiology
  • Hyperglycemia* / etiology
  • Hyperglycemia* / prevention & control
  • Ontario / epidemiology
  • Pandemics
  • Quality Improvement
  • Renal Dialysis / adverse effects